DaVita Inc. Extends Exchange Offer Expiration Date
DaVita Inc. announced today that it has extended the expiration date of its offer to exchange its 9 3% Series B Senior Subordinated Notes due 2011, registered under the Securities Act, for its...
Press Releases
DaVita Inc. Announces Exchange Offer for its 9 1/4% Senior Subordinated Notes Due 2011
DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9...
Davita Announces Second Quarter Earnings Release
We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on...
Nancy-Ann DeParle and William L. Roper Join DaVita Board of Directors
DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors...
DaVita says price of Amgen’s Epogen raised 3.9 pct
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...